[1]
A. K. Katsiaunis and S. Lipner, “Ocular Adverse Effects of TNF-α Inhibitors in the FDA Adverse Event Reporting System (FAERS)”, Journal of Clinical Dermatology and Surgery, vol. 2, no. 2, Aug. 2024, doi: 10.61853/1tvx5p21.